金河生物: 关于控股股东及一致行动人减持股份触及1%整数倍的公告

Core Viewpoint - The controlling shareholder of Jinhe Biological Technology Co., Ltd. plans to reduce its shareholding through a series of transactions, which is consistent with previously disclosed intentions and does not significantly impact the company [1][2][5]. Shareholding Reduction Plan - Jinhe Holdings intends to reduce its shareholding by up to 22,563,389 shares, representing no more than 3% of the company's total share capital, from June 10, 2025, to September 9, 2025 [1][4]. - The reduction will occur through two methods: a maximum of 7,521,130 shares (1% of total share capital) via centralized bidding and up to 15,042,259 shares (2% of total share capital) through block trading [1]. Recent Shareholding Changes - On August 11, 2025, Jinhe Holdings reduced its shareholding, resulting in a new holding of 273,679,052 shares, which is 36.3880% of the total share capital after the reduction [2][4]. - Prior to this reduction, the holding was 278,744,052 shares, accounting for 37.0615% of the total share capital [2][4]. Compliance and Impact - The recent shareholding reduction aligns with the previously disclosed reduction plan and is within the stated limits, indicating compliance with relevant regulations [5]. - The company asserts that this change in shareholding does not have a significant impact on its operations or governance [2][5].